A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries | Zendy

Philip Hasbak | Zendy; Ole Saetrum Opgaard | Zendy; Karen Eskesen | Zendy; Søren Schifter | Zendy; Henrik Arendrup | Zendy; J. Longmore | Zendy; Lars Edvinsson | Zendy

Open Access

A Novel Nonpeptide CGRP Receptor Antagonist, ‘Compound 1’ (WO98/11128) Is a High Affinity Competitive Antagonist at the CGRP1 Receptor in Human Coronary Arteries

Author(s) -

Philip Hasbak,

Ole Saetrum Opgaard,

Karen Eskesen,

Søren Schifter,

Henrik Arendrup,

J. Longmore,

Lars Edvinsson

Publication year - 2001

Publication title -

the scientific world journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.453

H-Index - 93

eISSN - 2356-6140

pISSN - 1537-744X

DOI - 10.1100/tsw.2001.416

Subject(s) - antagonist , competitive antagonist , calcitonin gene related peptide , receptor antagonist , receptor , pharmacology , coronary arteries , medicine , chemistry , artery , neuropeptide

P. Hasbak, O. Saetrum Opgaard, K. Eskesen, S. Schifter, H. Arendrup, J. Longmore, and L. Edvinsson Department of Clinical Experimental Research, University Hospital of Copenhagen, Glostrup, Denmark; Department of Clinical Physiology and Nuclear Medicine, University Hospital of Copenhagen, Glostrup, Denmark; Department of Pharmacology, College of Medicine, University of California at Irvine, Irvine, CA; Department of Thoracic Surgery, Rigshospitalet, Copenhagen, Denmark; Merck Sharp & Dohme, Neuroscience Research Centre, Harlow, Essex, U.K.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research